Top gbs Articles in Infectious Disease

Putative Novel Surface-Exposed Streptococcus agalactiae Protein Frequently Expressed by the Group B Streptococcus from Zimbabwe
Clinical and Vaccine Immunology, 09/22/2009

al. – The putative novel GBS protein named Z showed distinct capsular antigen associations and presented as an important phenotypic marker in GBS from Zimbabwe. It may be an important antigen in GBS from larger areas of southern Africa. Its prevalence in GBS from Western countries is not known [more...]

Little evidence that supports a causal link between most vaccines and Guillain-Barre syndrome
Drugs & Therapy Perspectives, 10/16/2009

the pathogenesis of Guillain–Barre syndrome (GBS). It is, therefore, biologically plausible that immunizations may be associated with subsequent GBS. In a recent review of the current body of evidence, associations between vaccines and GBS were generally found to have been only temporal, with [more...]

One Thing Leads to Another: GBS Complicated by PRES and Takotsubo Cardiomyopathy
Neurocritical Care, 10/12/2009

Fugate JE et al. – The autonomic effects of GBS may cause a variety of reversible clinical syndromes associated with sympathetic dysfunction including PRES and takotsubo cardiomyopathy; both of which are self ... hypotension in GBS may be caused in part by neurogenic stunned myocardium. [more...]

Bilateral facial nerve enhancement demonstrated by magnetic resonance imaging in Guillain–Barre
Neurological Sciences, 08/31/2009

50% of GBS patients clinically exhibit facial nerve involvement, it has never been demonstrated on MRI. The authors aimed to observe facial nerve involvement in a GBS patient who has prominent facial diplegia. With the guidance of the literature, they predict that MRI in selected GBS patients may be [more...]

Association between colonization with Group B Streptococcus and preterm delivery: A systematic review
Acta Obstetricia et Gynecologica Scandinavica, 08/19/2009

ndash; The systematic review did not show an association between maternal GBS colonization during pregnancy and preterm delivery. However, in case of preterm delivery, there is an increased risk of subsequent maternal GBS colonization. [more...]

Evaluation of a novel real-time PCR test based on the ssrA gene for the identification of group B streptococci in vaginal swabs
BMC Infectious Diseases, 09/09/2009

Wernecke M et al. – The RiboSEQ GBS test is a valuable method for the rapid, sensitive and specific detection of GBS in pregnant women. This study also validates the ssrA gene as a suitable and versatile target for nucleic acid [more...]

Genotyping of Streptococcus agalactiae isolated from vaginal and rectal swabs of women at 35-37 weeks of pregnancy
BMC Infectious Diseases, 09/14/2009

for GBS detection from vaginal and rectal swabs from pregnant women. The authors established a higher genotypic diversity per individual than other studies, with up to four different genotypes among a maximum of 6 isolates per individual picked. Still, 18 of the 19 women with GBS from both rectum [more...]

Selective Immune Adsorption Treatment of Severe Guillain Barre Syndrome in the Intensive Care Unit
Neurocritical Care, 08/03/2009

Galldiks N et al. – In severely affected GBS patients admitted to ICU treatment with SIA seems to be safe and effective. In comparison to treatment with SIA only, sequential therapy with IVIG was not more effective. [more...]

Comparison of Group B Streptococcal Colonization in the Pregnant Diabetic and Non-Diabetic Women
Acta Medica Iranica, 08/20/2009

colonization in diabetic group and difference was significant. Pregnant diabetic patients have higher carriage rates of group B streptococcus (GBS) in rectum than non–diabetic pregnant women and diabetes is a risk factor for group B streptococcus colonization during pregnancy. [more...]

Prevention of Group B Streptococcus early-onset disease: a toolkit by the California Perinatal Quality Care Collaborative
Journal of Perinatology, 08/07/2009

the CPQCC toolkit reflecting several population studies published since the 2002 guideline. Current epidemiological trends in incidence of EOD with GBS, changes in antibiotic sensitivity and the potential value of newer strategies are discussed. [more...]